Cowen Starts Novavax (NVAX) at Outperform, Analyst Sees Company as Positioned to Succeed

StreetInsider2022-01-22

Cowen analyst Georgi Yordanov initiated research coverage on Novavax (NASDAQ: NVAX) with an Outperform rating and a $150.00 per share ...(Premium-only article. Please sign in or upgrade to SI Premium ...

网页链接
免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法